In patients with submassive PE, about 1 in 7 have elevated cTnI, which is associated with a 3.5‐fold higher risk of all‐cause death but not with increased risk of recurrent venous thromboembolism. This evidence concerns the gene TNNI3 and venous thromboembolism.